GRACEcast Lung Cancer Audio

Dec 20 2013 136 ep. 15 mins 206
GRACEcast Lung Cancer Audio Podcast artwork

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

  Education
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Squamous Lung Cancer Part 5, Q and A Session (audio)

Dec 20 2013 13 mins  
Dr. David Spigel, Sarah Cannon Cancer Center, answers audience questions about squamous lung cancer.

Squamous Lung Cancer, Part 4: Immunotherapy (audio)

Dec 10 2013 7 mins  
Dr. David Spigel, Sarah Cannon Cancer Center, describes current research in immunotherapy as treatment for squamous lung cancer.

Squamous Lung Cancer, Part 3: Treatment (audio)

Dec 08 2013 12 mins  
Dr. David Spigel, Sarah Cannon Cancer Center, outlines treatment options for squamous lung cancer.

Squamous Lung Cancer, Part 2: Genomic Testing (audio)

Dec 06 2013 11 mins  
Dr. David Spigel, Sarah Cannon Cancer Center, discusses the importance of genomic testing in squamous lung cancer.

Squamous Lung Cancer, Part 1: Diagnosis, Presentation and Workup (audio)

Dec 02 2013 15 mins  
Dr. David Spigel, Sarah Cannon Cancer Center, describes the diagnosis, presentation and workup of squamous lung cancer.

ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC (audio)

Sep 04 2013 5 mins  
Dr. Edward Garon, David Geffen School of Medicine at UCLA, covers the provocative results of the novel immune checkpoint PD-L1 inhibitor MPDL3280A in advanced NSCLC.

ASCO Lung Cancer Highlights, Part 12: Ganetespib with Second Line Chemotherapy for Advanced NSCLC (audio)

Aug 30 2013 5 mins  
Dr. Edward Garon, David Geffen School of Medicine at UCLA, reviews impressive results from the GALAXY-1 trial of the heat shock protein inhibitor ganetespib combined with combined with second line docetaxel in advanced lung adenocarcinoma.

ASCO Lung Cancer Highlights, Part 11: Nintedanib with Second Line Chemotherapy for Advanced NSCLC (audio)

Aug 26 2013 5 mins  
Dr. Edward Garon, David Geffen School of Medicine at UCLA, discusses results in a trial that demonstrated a significant survival benefit with nintedanib combined with second line docetaxel in advanced lung adenocarcinoma.

ASCO Lung Cancer Highlights, Part 10: Strategies After Resistance to Crizotinib in ALK-Positive Advanced NSCLC (audio)

Aug 26 2013 5 mins  
Dr. Edward Garon, David Geffen School of Medicine at UCLA, describes the exciting developments with LDK-378 and potentially other second generation ALK inhibitors for crizotinib-resistant ALK-positive advanced NSCLC.

ASCO Lung Cancer Highlights, Part 9: The MADeIT Study of Predictive Biomarkers for Chemotherapy in Advanced NSCLC (audio)

Aug 23 2013 9 mins  
Dr. Edward Garon, David Geffen School of Medicine at UCLA, covers the results and implications of the MADeIT phase III randomized study of preductive biomarkers ERCC1 and RRM1 in advanced NSCLC.